Intravitreal Bevacizumab Injection Effect in Exudative Age Related Macular Degeneration
<p>Exudative age-related macular degeneration is the most common cause of vision loss of people over the age 60 in the developed countries. The cause is not clear yet, but since Avastin is largely used for the treatment, therefore, this study was conducted to assess the influence of avastin. &...
Bewaard in:
Hoofdauteurs: | Gholamhossein Yaghoobi (Auteur), Abbas Ataei Kachuei (Auteur) |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Journal of Clinical Research and Ophthalmology - Peertechz Publications,
2016-03-07.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Gelijkaardige items
-
Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration
door: Gebran Khneizer, et al.
Gepubliceerd in: (2017) -
Evaluation of Aqueous Flare Intensity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-Related Macular Degeneration
door: Joanna Dolar-Szczasny, et al.
Gepubliceerd in: (2021) -
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
door: Wataru Kikushima, et al.
Gepubliceerd in: (2023) -
Improvement of Diabetic Macular Edema in the Fellow Eye After Monocular Intravitreal Bevacizumab Injection
door: Hamidreza Torabi
Gepubliceerd in: (2017) -
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
door: Laura García-Quintanilla, et al.
Gepubliceerd in: (2019)